Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: The Insulin Resistance Atherosclerosis Study

Diabetes Care

Volumn 21, Issue 11, 1998, Pages 1812-1818

  Wagenknecht, Lynne E ^a   D'Agostino Jr , Ralph B ^a   Haffner, Steven M ^b   Savage, Peter J ^c   Rewers, Marian ^d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; TUNICA MEDIA;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ARTERIOSCLEROSIS; BLOOD GLUCOSE; CAROTID ARTERIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSE TOLERANCE TEST; HISPANIC AMERICANS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; RISK FACTORS; SMOKING;

EID: 0031724917     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.11.1812     Document Type: Article

References (48)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. JAMA 241:2035-2038, 1979
2. Stamler R, Stamler J (Eds.): Asymptomatic hyperglycaemia and coronary heart disease: a series of papers by the International Collaborative Group, based on studies on fifteen populations J Chron Dis 32:681-837, 1979
3. Barrett-Connor E: Does hyperglycemia really cause coronary heart disease? Diabetes Care 20:1620-1623, 1997
4. Haffner SM: Impaired glucose tolerance: is it relevant for cardiovascular disease? Diabetologia 40 (Suppl. 2):S138-S140, 1997
5. Epstein FH: Hyperglycaemia as a risk factor for coronary heart disease. Monogr Atheroscler 13:92-97, 1985
6. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG, for the Atherosclerosis Risk in Communities (ARIC) Study Investigators: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity Stroke 25:66-73, 1994
7. Niskanen L, Rauramaa R, Miettinen H, Haffner SM, Mercuri M, Uusitupa M: Carotid artery intima-media thickness in elderly patients with NIDDM and in non-diabetic subjects. Stroke 27:1986-1992, 1996
8. Yamasaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, Kajimoto Y, Kamada T: Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery Diabetologia 38:585-591, 1995
9. Wagenknecht LE, Mayer EJ, Rewers M, Haffner S, Selby J, Borok GM, Henkin L, Howard G, Savage PJ, Saad MF, Bergman RN, Hamman R: The Insulin Resistance Atherosclerosis Study (IRAS): objectives, design, and recruitment results. Ann Epidemiol 5:464-471, 1995
10. Lipid Research Clinics Program: Manual of Laboratory Operations, Vol 1, Lipid and Lipoprotein Analysis, Bethesda, MD, Department of Health, Education, and Welfare, 1974 (NIH publ. no. 75-628)
11. Bergman RN, Finegood DT, Ader M: Assessment of insulin sensitivity in vivo. Endocr Rev 6:45-86, 1985
12. Pacini G, Bergman RN: MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed 23:113-122, 1986
13. DeClerck PJ, Alessi MC, Verstreken M, Kruithof EK, Juhan-Vague I, Collen D: Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay Blood 71:220-225, 1988
14. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
15. Lohman TG: Stature, recumbent length, and weight. In Anthropometric Standardization Reference Manual. Roche AF, Martorell R, Eds. Champaign, IL, Human Kinetics, 1991, p, 3-8
16. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R: Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 74:1399-1406, 1986
17. O'Leary DH, Polak JF, Wolfson SK, Bond MG, Bommer W, Sheth S, Psaty BM, Sharrett AR, Manolio TA: Use of sonography to evaluate carotid atherosclerosis in the elderly: the Cardiovascular Health Study. Stroke 22:1155-1163, 1991
18. Wong M, Edelstein J, Wollman J, Bond MG: Ultrasonic-pathological comparison of the human arterial wall: verification of intima-media thickness. Arterioscler Thromb 13:482-486, 1993
19. Wagenknecht LE, D'Agostino RD Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM: Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke 28:999-1005, 1997
20. DeStefano F, Newman J: Comparison of coronary heart disease monality risk between black and white people with diabetes. Ethn Dis 3:145-151, 1993
21. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH: A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 20:935-942, 1997
22. Stamler J, Vaccaro O, Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434-444, 1993
23. Rewers M, Shetterly SM, Baxter J, Marshall JA, Hamman RF: Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population: the San Luis Valley Diabetes Study Am J Epidemiol 135:1321-1330, 1992
24. D'Agostino RB Jr, Burke G, O'Leary D, Rewers M, Selby J, Savage PJ, Saad MF, Bergman RN, Howard G, Wagenknecht L, Haffner SM: Ethnic differences in carotid wall thickness: the Insulin Resistance Atherosclerosis Study Stroke 27:1744-1749, 1996
25. Haffner SM, D'Agostino RB Jr, Saad MF, Rewers M, Mykkanen L, Selby J, Howard G, Savage PJ, Hamman R, Wagenknecht LE, Bergman RN: Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared to non-Hispanic whites: the Insulin Resistance Atherosclerosis Study Diabetes 45:742-748, 1996
26. Persson J, Formgren J, Israelsson B, Berglund G: Ultrasound-determined intima-media thickness and atherosclerosis: direct and indirect validation. Arterioscler Thromb 14:261-264, 1994
27. Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C, the ARIC Investigators: Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC Study. Am J Epidemiol 134:250-256, 1991
28. Crouse JR, Toole JF, McKinney WM, Dignan MB, Howard G, Kahl FR, McMahan MR, Harpold GH: Risk factors for extracranial carotid artery atherosclerosis. Stroke 18:990-996, 1987
29. Visona A, Pesavento R, Lusiani L, Bonanome A, Cemetti C, Rossi M, Maiolino P, Pagnan A: Intimai medial thickening of common carotid artery as indicator of coronary artery disease. Angiology 47:61-66, 1996
30. Wofford JL, Kahl FR, Howard GR, McKinney WM, Toole JF, Crouse JR: Relation of extent of extracranial carotid artery atherosclerosis as measured by B-mode ultrasound to the extent of coronary atherosclerosis. Arterioscler Thromb 11:1786-1794, 1991
31. Salonen JT, Salonen R: Ultrasound B-mode imaging in observational studies of atherosclerotic progression, Circulation 87 (Suppl. 2):56-65, 1993
32. Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX: Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors; the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146:483-494, 1997
33. Furberg CD, Adams HP, Applegate WB, Byington RP, Espeland MA, Hartwell T, Hunninghake DB, Lefkowitz DS, Probstfield J, Riley WA, Young B, for the Asymp- tomatic Carotid Artery Progression Study (ACAPS) Research Group: Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 90:1679-1687, 1994
34. Blankenhorn DH, Selzer RH, Crawford DW, Banh JD, Liu CR, Liu CH, Mack WJ, Alaupovic P: Beneficial effects of colestipolniacin therapy on the common carotid artery: two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation 88:20-28, 1993
35. Riley WA, Bames RW, Applegate WB, Dempsey R, Hartwell T, Davis VG, Bond MG, Furberg CD: Reproducibility of non-invasive ultrasonic measurement of carotid atherosclerosis: the Asymptomatic Carotid Artery Plaque Study. Stroke 23:1062-1068, 1992
36. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R: Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817, 1996
37. Yudkin JS, Alberti KGMM, McLarty DG, Swai ABM: Impaired glucose tolerance: is it a risk factor for diabetes or a diagnostic ragbag? BMJ 301:397-402, 1990
38. Orchard TJ: The impact of gender and general risk factors on the occurrence of atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Ann Med 28:323-333, 1996
39. Glagov S, Zarins C, Giddens DP, Ku DN: Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries. Arch Pathol Lab Med 112:1018-1031, 1988
40. O'Leary DH, Polak JF, Kronmal RA, Savage PJ, Borhani NO, Kittner SJ, Tracy R, Gardin JM, Price TR, Furberg CD, for the Cardiovascular Health Study Collaborative Research Group: Thickening of the carotid wall: a marker for atherosclerosis in the elderly? Stroke 27:224-231, 1996
41. Gerrity RG, Nadler JL, Natarajan R: Oxidant stress in a new swine model of diabetes-induced accelerated atherosclerosis (Abstract). Circulation 96:1-175, 1997
42. Salonen JT, Nyyssonen K, Salonen R, Porkkala-Sarataho E, Tuomainen T, Diczfalusy U, Bjorkhem I: Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 95:840-845, 1997
43. Haffner SM, Agil A, Mykkanen L, Stern MR, Jialal I: Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM. Diabetes Care 18:646-653, 1995
44. Yegin A, Ozben T, Yegin H: Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus, Int J Clin Lab Res 25:157-161, 1995
45. Lyons TJ: Lipoprotein glycation and its metabolic consequences. Diabetes 41 (Suppl. 2):67-73, 1992
46. Haffner SM, Stem MP, Hazuda HP, Mitchell BD, Patterson JK: Cardiovascular risk factors in confirmed prediabetic individuals: does the clock for coronary heart disease stan ticking before the onset of clinical diabetes? JAMA 263:2893-2898, 1990
47. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH: The natural history of impaired glucose tolerance in the Pima Indians. N Engl. J Med 319:1500-1506, 1988
48. Savage PJ: Cardiovascular complications of diabetes mellitus: what we know and what we need to know about their prevention. Ann Intern Med 124:123-126, 1996